Related Experiment Video
Updated: Jul 13, 2025
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Molecular tumour boards - current and future considerations for precision oncology
Apostolia M Tsimberidou1, Michael Kahle2, Henry Hiep Vo3
1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. atsimber@mdanderson.org.
Molecular tumor boards (MTBs) are crucial for matching cancer patients to targeted therapies. Their role is expanding in precision oncology, but challenges like funding and accessibility need addressing for improved patient care.
Area of Science:
- Oncology
- Genomics
- Translational Medicine
Background:
- Rapid advancements in developmental therapeutics and targeted therapies for cancer.
- Molecular tumor boards (MTBs) interpret molecular profiling to match patients with treatments.
- The complexity of molecular alterations and treatment selection necessitates expert review.
Purpose of the Study:
- To discuss the evolving role of Molecular Tumor Boards (MTBs) in precision oncology.
- To highlight current considerations and future directions for MTB implementation.
- To emphasize the importance of MTBs in optimizing biomarker-directed therapy allocation.
Main Methods:
- Review of molecular profiling results for individual cancer patients.
- Expert panel review and interpretation of complex molecular alterations.
- Matching patients to available targeted therapies, including investigational drugs.
Main Results:
- MTBs play an increasingly vital role in precision oncology.
- Challenges include the growing number of molecular alterations and evolving clinical significance.
- Increased MTB availability and performance can improve patient care.
Conclusions:
- MTBs are essential for navigating complex molecular data in cancer treatment.
- Addressing challenges in funding, resources, and accessibility is critical for MTB sustainability and outreach.
- Harmonization of practice and policy is needed for optimal precision oncology implementation.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...